Cargando…

A DNA adductome analysis revealed a reduction in the global level of C5-hydroxymethyl-2′-deoxycytidine in the non-tumoral upper urinary tract mucosa of urothelial carcinoma patients

BACKGROUND: DNA adducts, covalent modifications to DNA due to exposure to specific carcinogens, cause the mispairing of DNA bases, which ultimately results in DNA mutations. DNA methylation in the promoter region, another type of DNA base modification, alters the DNA transcription process, and has b...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsushita, Yuto, Iwashita, Yuji, Ohtsuka, Shunsuke, Ohnishi, Ippei, Yamashita, Takashi, Miyake, Hideaki, Sugimura, Haruhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638144/
https://www.ncbi.nlm.nih.gov/pubmed/34852853
http://dx.doi.org/10.1186/s41021-021-00228-9
_version_ 1784608892562440192
author Matsushita, Yuto
Iwashita, Yuji
Ohtsuka, Shunsuke
Ohnishi, Ippei
Yamashita, Takashi
Miyake, Hideaki
Sugimura, Haruhiko
author_facet Matsushita, Yuto
Iwashita, Yuji
Ohtsuka, Shunsuke
Ohnishi, Ippei
Yamashita, Takashi
Miyake, Hideaki
Sugimura, Haruhiko
author_sort Matsushita, Yuto
collection PubMed
description BACKGROUND: DNA adducts, covalent modifications to DNA due to exposure to specific carcinogens, cause the mispairing of DNA bases, which ultimately results in DNA mutations. DNA methylation in the promoter region, another type of DNA base modification, alters the DNA transcription process, and has been implicated in carcinogenesis in humans due to the down-regulation of tumor suppressor genes. Difficulties are associated with demonstrating the existence of DNA adducts or chemically modified bases in the human urological system. Apart from aristolochic acid-DNA adducts, which cause urothelial carcinoma and endemic nephropathy in a particular geographical area (Balkan), limited information is currently available on DNA adduct profiles in renal cell carcinoma and upper urinary tract urothelial carcinoma, including renal pelvic cancer and ureteral cancer. METHOD: To elucidate the significance of DNA adducts in carcinogenesis in the urothelial system, we investigated 53 DNA adducts in the non-tumoral renal parenchyma and non-tumoral renal pelvis of patients with renal cell carcinoma, upper urinary tract urothelial carcinoma, and other diseases using liquid chromatography coupled with tandem mass spectrometry. A comparative analysis of tissue types, the status of malignancy, and clinical characteristics, including lifestyle factors, was performed. RESULTS: C5-Methyl-2′-deoxycytidine, C5-hydroxymethyl-2′-deoxycytidine (5hmdC), C5-formyl-2′-deoxycytidine, 2′-deoxyinosine, C8-oxo-2′-deoxyadenosine, and C8-oxo-2′-deoxyguanosine (8-OHdG) were detected in the renal parenchyma and renal pelvis. 8-OHdG was more frequently detected in the renal pelvis than in the renal cortex and medulla (p = 0.048 and p = 0.038, respectively). 5hmdC levels were significantly lower in the renal pelvis of urothelial carcinoma patients (n = 10) than in the urothelium of patients without urothelial carcinoma (n = 15) (p = 0.010). Regarding 5hmdC levels in the renal cortex and medulla, Spearman’s rank correlation test revealed a negative correlation between age and 5hmdC levels (r = − 0.46, p = 0.018 and r = − 0.45, p = 0.042, respectively). CONCLUSIONS: The present results revealed a reduction of 5hmdC levels in the non-tumoral urinary tract mucosa of patients with upper urinary tract urothelial carcinoma. Therefore, the urothelial cell epithelia of patients with upper urinary tract cancer, even in non-cancerous areas, may be predisposed to urothelial cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41021-021-00228-9.
format Online
Article
Text
id pubmed-8638144
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-86381442021-12-02 A DNA adductome analysis revealed a reduction in the global level of C5-hydroxymethyl-2′-deoxycytidine in the non-tumoral upper urinary tract mucosa of urothelial carcinoma patients Matsushita, Yuto Iwashita, Yuji Ohtsuka, Shunsuke Ohnishi, Ippei Yamashita, Takashi Miyake, Hideaki Sugimura, Haruhiko Genes Environ Research BACKGROUND: DNA adducts, covalent modifications to DNA due to exposure to specific carcinogens, cause the mispairing of DNA bases, which ultimately results in DNA mutations. DNA methylation in the promoter region, another type of DNA base modification, alters the DNA transcription process, and has been implicated in carcinogenesis in humans due to the down-regulation of tumor suppressor genes. Difficulties are associated with demonstrating the existence of DNA adducts or chemically modified bases in the human urological system. Apart from aristolochic acid-DNA adducts, which cause urothelial carcinoma and endemic nephropathy in a particular geographical area (Balkan), limited information is currently available on DNA adduct profiles in renal cell carcinoma and upper urinary tract urothelial carcinoma, including renal pelvic cancer and ureteral cancer. METHOD: To elucidate the significance of DNA adducts in carcinogenesis in the urothelial system, we investigated 53 DNA adducts in the non-tumoral renal parenchyma and non-tumoral renal pelvis of patients with renal cell carcinoma, upper urinary tract urothelial carcinoma, and other diseases using liquid chromatography coupled with tandem mass spectrometry. A comparative analysis of tissue types, the status of malignancy, and clinical characteristics, including lifestyle factors, was performed. RESULTS: C5-Methyl-2′-deoxycytidine, C5-hydroxymethyl-2′-deoxycytidine (5hmdC), C5-formyl-2′-deoxycytidine, 2′-deoxyinosine, C8-oxo-2′-deoxyadenosine, and C8-oxo-2′-deoxyguanosine (8-OHdG) were detected in the renal parenchyma and renal pelvis. 8-OHdG was more frequently detected in the renal pelvis than in the renal cortex and medulla (p = 0.048 and p = 0.038, respectively). 5hmdC levels were significantly lower in the renal pelvis of urothelial carcinoma patients (n = 10) than in the urothelium of patients without urothelial carcinoma (n = 15) (p = 0.010). Regarding 5hmdC levels in the renal cortex and medulla, Spearman’s rank correlation test revealed a negative correlation between age and 5hmdC levels (r = − 0.46, p = 0.018 and r = − 0.45, p = 0.042, respectively). CONCLUSIONS: The present results revealed a reduction of 5hmdC levels in the non-tumoral urinary tract mucosa of patients with upper urinary tract urothelial carcinoma. Therefore, the urothelial cell epithelia of patients with upper urinary tract cancer, even in non-cancerous areas, may be predisposed to urothelial cancer. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s41021-021-00228-9. BioMed Central 2021-12-02 /pmc/articles/PMC8638144/ /pubmed/34852853 http://dx.doi.org/10.1186/s41021-021-00228-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Matsushita, Yuto
Iwashita, Yuji
Ohtsuka, Shunsuke
Ohnishi, Ippei
Yamashita, Takashi
Miyake, Hideaki
Sugimura, Haruhiko
A DNA adductome analysis revealed a reduction in the global level of C5-hydroxymethyl-2′-deoxycytidine in the non-tumoral upper urinary tract mucosa of urothelial carcinoma patients
title A DNA adductome analysis revealed a reduction in the global level of C5-hydroxymethyl-2′-deoxycytidine in the non-tumoral upper urinary tract mucosa of urothelial carcinoma patients
title_full A DNA adductome analysis revealed a reduction in the global level of C5-hydroxymethyl-2′-deoxycytidine in the non-tumoral upper urinary tract mucosa of urothelial carcinoma patients
title_fullStr A DNA adductome analysis revealed a reduction in the global level of C5-hydroxymethyl-2′-deoxycytidine in the non-tumoral upper urinary tract mucosa of urothelial carcinoma patients
title_full_unstemmed A DNA adductome analysis revealed a reduction in the global level of C5-hydroxymethyl-2′-deoxycytidine in the non-tumoral upper urinary tract mucosa of urothelial carcinoma patients
title_short A DNA adductome analysis revealed a reduction in the global level of C5-hydroxymethyl-2′-deoxycytidine in the non-tumoral upper urinary tract mucosa of urothelial carcinoma patients
title_sort dna adductome analysis revealed a reduction in the global level of c5-hydroxymethyl-2′-deoxycytidine in the non-tumoral upper urinary tract mucosa of urothelial carcinoma patients
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8638144/
https://www.ncbi.nlm.nih.gov/pubmed/34852853
http://dx.doi.org/10.1186/s41021-021-00228-9
work_keys_str_mv AT matsushitayuto adnaadductomeanalysisrevealedareductioninthegloballevelofc5hydroxymethyl2deoxycytidineinthenontumoralupperurinarytractmucosaofurothelialcarcinomapatients
AT iwashitayuji adnaadductomeanalysisrevealedareductioninthegloballevelofc5hydroxymethyl2deoxycytidineinthenontumoralupperurinarytractmucosaofurothelialcarcinomapatients
AT ohtsukashunsuke adnaadductomeanalysisrevealedareductioninthegloballevelofc5hydroxymethyl2deoxycytidineinthenontumoralupperurinarytractmucosaofurothelialcarcinomapatients
AT ohnishiippei adnaadductomeanalysisrevealedareductioninthegloballevelofc5hydroxymethyl2deoxycytidineinthenontumoralupperurinarytractmucosaofurothelialcarcinomapatients
AT yamashitatakashi adnaadductomeanalysisrevealedareductioninthegloballevelofc5hydroxymethyl2deoxycytidineinthenontumoralupperurinarytractmucosaofurothelialcarcinomapatients
AT miyakehideaki adnaadductomeanalysisrevealedareductioninthegloballevelofc5hydroxymethyl2deoxycytidineinthenontumoralupperurinarytractmucosaofurothelialcarcinomapatients
AT sugimuraharuhiko adnaadductomeanalysisrevealedareductioninthegloballevelofc5hydroxymethyl2deoxycytidineinthenontumoralupperurinarytractmucosaofurothelialcarcinomapatients
AT matsushitayuto dnaadductomeanalysisrevealedareductioninthegloballevelofc5hydroxymethyl2deoxycytidineinthenontumoralupperurinarytractmucosaofurothelialcarcinomapatients
AT iwashitayuji dnaadductomeanalysisrevealedareductioninthegloballevelofc5hydroxymethyl2deoxycytidineinthenontumoralupperurinarytractmucosaofurothelialcarcinomapatients
AT ohtsukashunsuke dnaadductomeanalysisrevealedareductioninthegloballevelofc5hydroxymethyl2deoxycytidineinthenontumoralupperurinarytractmucosaofurothelialcarcinomapatients
AT ohnishiippei dnaadductomeanalysisrevealedareductioninthegloballevelofc5hydroxymethyl2deoxycytidineinthenontumoralupperurinarytractmucosaofurothelialcarcinomapatients
AT yamashitatakashi dnaadductomeanalysisrevealedareductioninthegloballevelofc5hydroxymethyl2deoxycytidineinthenontumoralupperurinarytractmucosaofurothelialcarcinomapatients
AT miyakehideaki dnaadductomeanalysisrevealedareductioninthegloballevelofc5hydroxymethyl2deoxycytidineinthenontumoralupperurinarytractmucosaofurothelialcarcinomapatients
AT sugimuraharuhiko dnaadductomeanalysisrevealedareductioninthegloballevelofc5hydroxymethyl2deoxycytidineinthenontumoralupperurinarytractmucosaofurothelialcarcinomapatients